Table 2.

DEmiRNAs between PAAD and normal controls

	miRNAs	LogFC	P-value	FDR
Upregulated	hsa-miR194-1	2.995	3.92−4	3.54−2
	hsa-miR194-2	2.9078	4.75−4	3.82−2
Downregulated	hsa-miR139	−2.9103	5.72−16	8.28−13
	hsa-miR451a	−3.1417	1.97−11	1.42−8
	hsa-miR4433b	−4.7319	1.09−1	5.28−8
	hsa-miR142	−2.1612	4.18−9	1.51−6
	hsa-miR144	−2.6036	3.00−7	8.68−5
	hsa-miR424	−1.3554	4.69−7	1.13−4
	hsa-miR126	−1.1608	5.99−5	1.24−2
	hsa-miR486-1	−1.9358	1.87−4	3.01−2
	hsa-miR486-2	−1.8879	2.80−4	3.46−2
	hsa-miR891b	−2.4688	3.07−4	3.46−2
	hsa-miR10b	−1.107	3.21−4	3.46−2
	hsa-miR3613	−1.0856	3.35−4	3.46−2
	hsa-miR206	−2.4482	3.82−4	3.54−2
	hsa-miR4678	−2.8038	5.07−4	3.86−2

Abbreviations: DEmiRNAs, differently expressed miRNAs; FC, fold change; FDR, false-discovery rate; PAAD, pancreatic adenocarcinoma.